CRBP Corbus Pharmaceuticals Holdings Inc.

7.47
+0.6  (+9%)
Previous Close 6.87
Open 7.35
Price To Book 17.37
Market Cap 481032301
Shares 64,395,221
Volume 4,172,953
Short Ratio
Av. Daily Volume 1,780,496

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2b data due 2020.
Anabasum (Resunab)
Cystic Fibrosis
Phase 2 trial initiation announced December 22, 2017.
Anabasum (Resunab)
Systemic lupus erythematosus (SLE)
Phase 3 trial initiation announced December 17, 2018.
Lenabasum (resunab) - DETERMINE
Dermatomyositis
Phase 3 data due 2020.
Resunab
Systemic Sclerosis

Latest News

  1. SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Corbus Pharmaceuticals Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
  2. The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ASTE, CAG, INGN and CRBP
  3. SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corbus Pharmaceuticals Holdings, Inc. – CRBP
  4. Here's Why Corbus Pharmaceuticals Is on the Move Today
  5. CLASS ACTION UPDATE for AMRN, CNDT, NIO and CRBP: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
  6. Bronstein, Gewirtz & Grossman, LLC Class Action Update: BPI, CRBP & NIO
  7. Edited Transcript of CRBP earnings conference call or presentation 12-Mar-19 12:30pm GMT
  8. Is Corbus Pharmaceuticals Holdings (CRBP) Stock Outpacing Its Medical Peers This Year?
  9. FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of DBVT, AMRN, WTW and CRBP
  10. SHAREHOLDER ALERT: DBVT VALE SVXY CRBP: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
  11. SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Announces Class Action Against Corbus Pharmaceuticals Holdings, Inc. (CRBP) and Lead Deadline: May 13, 2019
  12. CRBP CLASS ACTION ALERT: Hagens Berman Alerts Corbus Pharmaceutical Holdings (NASDAQ: CRBP) Investors to May 13, 2019 Lead Plaintiff Deadline
  13. Glancy Prongay & Murray LLP Announces Investigation on Behalf of Corbus Pharmaceuticals Holdings, Inc. Investors
  14. Corbus Pharmaceuticals (CRBP) Upgraded to Strong Buy: Here's Why
  15. The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MAXR, BRS, WTW and CRBP
  16. SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Announces Class Action Against Corbus Pharmaceuticals Holdings, Inc. (CRBP) and Lead Plaintiff Deadline: May 13, 2019
  17. EQUITY ALERT: Rosen Law Firm Encourages Corbus Pharmaceuticals Holdings, Inc. Investors with Over $100K in Losses to Contact the Firm – CRBP
  18. CLASS ACTION UPDATE for SPB, ARLO, AMRN and CRBP: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders